ClinConnect ClinConnect Logo
Search / Trial NCT05085223

Prospective Analysis Into Development of Hypernatremia in Critically Ill Patients

Launched by CATHARINA ZIEKENHUIS EINDHOVEN · Oct 7, 2021

Trial Information

Current as of May 14, 2025

Unknown status

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Admitted to Intensive Care Unit
  • Age 18 years or older
  • Exclusion Criteria:
  • Age 17 years or younger

About Catharina Ziekenhuis Eindhoven

Catharina Ziekenhuis Eindhoven is a leading healthcare institution in the Netherlands, dedicated to delivering high-quality patient care and advancing medical research. As a prominent clinical trial sponsor, the hospital is committed to facilitating innovative research initiatives that aim to improve treatment outcomes and enhance patient quality of life. With a diverse range of medical specialties and a collaborative approach, Catharina Ziekenhuis Eindhoven fosters an environment that supports rigorous clinical trials, ensuring adherence to ethical standards and regulatory guidelines while prioritizing patient safety and well-being. Through its robust infrastructure and expertise, the hospital actively contributes to the development of new therapies and medical technologies, playing a vital role in the evolution of healthcare.

Locations

Eindhoven, Noord Brabant, Netherlands

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials